News: ZLD Zelda Therapeutics Posts HY Comprehensive Loss For Period Of $2.6 Mln, page-61

there is a clear disconnect between zeliras deliverables to date and capacity to attract investor interest.

i have emailed richard and ossagie on behalf of my self and a few investors i know personally in attempt to understand if they have identifed this gap and if they have developed a strategy to execute alongside any future business development that can address this challenge.

i think its important to know if key value drivers like

establishing US operational team
aquiring mature stage product ranges
Licencing deals
maiden revenues
clinically validating 'world first' insomnia asset
Milestone Opiod trial development

have been recognised in thier failure to unlock value for investors and if the team has anything in place to launch alongside future business deliverables.

just saying ... the business is a public company and has a simultaneous responsibility to deliver investor returns as well as its business plan.

im curious to see if me and my freinds choose to hold this investment.